Guardant Health (GH) Misses Q1 EPS by 4c, provides guidance

Guardant Health (NASDAQ: GH) reported Q1 EPS of ($0.85), $0.04 worse than the analyst estimate of ($0.81). Revenue for the quarter came in at $301.7 million versus the consensus estimate of $279.25 million.

GUIDANCE:

Guardant Health sees FY2026 revenue of $1.3-1.32 billion, versus the consensus of $1.271 billion.

For earnings history and earnings-related data on Guardant Health (GH) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Barclays Upgrades Schott Pharma AG (1SXP:GR) to Overweight
• Nse Said To Seek Up To $55 Billion Valuation In India Ipo - Bloomberg